The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases



Status:Archived
Conditions:Cancer, Cancer, Infectious Disease
Therapuetic Areas:Immunology / Infectious Diseases, Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:May 2008

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

The purpose of this study is to determine the biodistribution of a new agent 1-L-(2
deoxy-2,-18fluoroarabinofuranosyl) cytosine non-invasively in healthy humans and to evaluate
whether it can be used to image cancer, autoimmune disease, and inflammation



We found this trial at
1
site
David Geffen School of Medicine, UCLA
10833 Le Conte Ave
Los Angeles, California 90095
(310) 825-4321
David Geffen School of Medicine, UCLA In 2002 Mr. David Geffen announced a $200 million...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials